Literature DB >> 4351979

Activation and inhibition of blood platelet adenylate cyclase by adenosine or by 2-chloroadenosine.

R J Haslam, J A Lynham.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4351979     DOI: 10.1016/0024-3205(72)90269-x

Source DB:  PubMed          Journal:  Life Sci II        ISSN: 0300-9637


× No keyword cloud information.
  20 in total

Review 1.  Regulation of adenylate cyclase by adenosine.

Authors:  J N Fain; C C Malbon
Journal:  Mol Cell Biochem       Date:  1979-06-15       Impact factor: 3.396

2.  Stimulatory and inhibitory effects of cyclic AMP on pancreatic glucagon release from monolayer cultures and the controlling role of calcium.

Authors:  C B Wollheim; B Blondel; A E Renold; G W Sharp
Journal:  Diabetologia       Date:  1976-07       Impact factor: 10.122

3.  Characterization of alpha- and beta-adrenergic receptors linked to human platelet adenylate cyclase.

Authors:  K H Jakobs; W Saur; G Schultz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-05       Impact factor: 3.000

4.  Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.

Authors:  R J Haslam; M M Davidson; J V Desjardins
Journal:  Biochem J       Date:  1978-10-15       Impact factor: 3.857

5.  Adenosine analogs inhibit adipocyte adenylate cyclase by a GTP-dependent process: basis for actions of adenosine and methylxanthines on cyclic AMP production and lipolysis.

Authors:  C Londos; D M Cooper; W Schlegel; M Rodbell
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

6.  Two distinct adenosine-sensitive sites on adenylate cyclase.

Authors:  C Londos; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

Review 7.  Mechanism of platelet function with particular reference to the effects of drugs acting as inhibitors.

Authors:  E F Lüscher
Journal:  Agents Actions       Date:  1978-04

8.  Detection of 23-27 kDa GTP-binding proteins in platelets and other cells.

Authors:  R P Bhullar; R J Haslam
Journal:  Biochem J       Date:  1987-07-15       Impact factor: 3.857

Review 9.  Current issues in thrombosis prevention with antiplatelet drugs.

Authors:  G de Gaetano; C Cerletti; E Dejana; J Vermylen
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

10.  13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor.

Authors:  G C Le Breton; D L Venton; S E Enke; P V Halushka
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.